• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国活体肝移植:识别围手术期并发症风险的供体

Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications.

作者信息

Patel S, Orloff M, Tsoulfas G, Kashyap R, Jain A, Bozorgzadeh A, Abt P

机构信息

Division of Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.

出版信息

Am J Transplant. 2007 Oct;7(10):2344-9. doi: 10.1111/j.1600-6143.2007.01938.x.

DOI:10.1111/j.1600-6143.2007.01938.x
PMID:17845568
Abstract

Donor safety has been scrutinized by both the medical community and the media. Variability exists in reported donor complications and associated risk factors are ill defined. Use of administrative data can overcome the bias of single-center studies and explore variables associated with untoward events. A retrospective cohort study identifying living liver donors in two large healthcare registries yielded 433 right and left lobe donors from 13 centers between 2001 and 2005. Perioperative complications were identified using International Classification of Diseases, 9th Revision (ICD-9) coding data and classified according to the Clavien system. Logistic regression models identified factors associated with complications. There was one perioperative death (0.23%). The overall complication rate was 29.1% and major complication rate defined by a Clavien grade >or=3 was 3.5%. Center living-donor volume (OR = 0.97, 95% CI = 0.95-0.99) and the ratio of living-donors to all donors (living and deceased) (OR = 0.94, 95% CI = 0.92-0.96) were associated with a lower risk of all complications. Donor age >50 years (OR = 4.25, 95% CI = 1.22-14.87) was associated with a higher risk of major complications. Living liver donation is currently performed with a low risk of major morbidity. Use of administrative data represents an important tool to facilitate a better understanding of donor risk factors.

摘要

供体安全问题受到了医学界和媒体的审视。报告的供体并发症存在差异,相关风险因素也不明确。使用行政数据可以克服单中心研究的偏差,并探索与不良事件相关的变量。一项回顾性队列研究在两个大型医疗登记处识别活体肝供体,2001年至2005年间从13个中心获得了433例右叶和左叶供体。使用国际疾病分类第九版(ICD-9)编码数据识别围手术期并发症,并根据Clavien系统进行分类。逻辑回归模型确定了与并发症相关的因素。有1例围手术期死亡(0.23%)。总体并发症发生率为29.1%,Clavien分级≥3级定义的主要并发症发生率为3.5%。中心活体供体数量(OR = 0.97,95%CI = 0.95 - 0.99)以及活体供体与所有供体(活体和已故)的比例(OR = 0.94,95%CI = 0.92 - 0.96)与所有并发症的较低风险相关。供体年龄>50岁(OR = 4.25,95%CI = 1.22 - 14.87)与主要并发症的较高风险相关。目前进行活体肝捐赠时严重发病风险较低。使用行政数据是促进更好地理解供体风险因素的重要工具。

相似文献

1
Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications.美国活体肝移植:识别围手术期并发症风险的供体
Am J Transplant. 2007 Oct;7(10):2344-9. doi: 10.1111/j.1600-6143.2007.01938.x.
2
Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States.降低器官捐献的发病率:美国活体供肾肾切除术后围手术期并发症的因素分析
Transplantation. 2008 Feb 27;85(4):561-5. doi: 10.1097/TP.0b013e3181643ce8.
3
Donor morbidity after living donation for liver transplantation.活体肝移植供体的术后并发症
Gastroenterology. 2008 Aug;135(2):468-76. doi: 10.1053/j.gastro.2008.04.018. Epub 2008 Apr 22.
4
Donor safety in living donor liver transplantation: The Korean organ transplantation registry study.活体肝移植中供体的安全性:韩国器官移植登记研究
Liver Transpl. 2017 Aug;23(8):999-1006. doi: 10.1002/lt.24778.
5
Operative morbidity of living liver donors in Japan.日本活体肝供体的手术并发症发生率
Lancet. 2003 Aug 30;362(9385):687-90. doi: 10.1016/S0140-6736(03)14230-4.
6
Donor safety in living donor liver donation: An Italian multicenter survey.活体肝移植中供体的安全性:一项意大利多中心调查。
Liver Transpl. 2017 Feb;23(2):184-193. doi: 10.1002/lt.24651. Epub 2016 Dec 30.
7
Right lobe living donors ages 55 years old and older in liver transplantation.肝移植中 55 岁及以上右叶活体供者。
Liver Transpl. 2017 Oct;23(10):1305-1311. doi: 10.1002/lt.24823.
8
Morbidity and mortality of hepatic right lobe living donors: systematic review and perspectives.肝右叶活体供者的发病率和死亡率:系统评价与展望
J Gastrointestin Liver Dis. 2018 Jun;27(2):169-178. doi: 10.15403/jgld.2014.1121.272.mor.
9
Donor outcome after living liver donation: a single-center experience.活体肝移植供体的术后转归:单中心经验
Transplant Proc. 2007 May;39(4):829-34. doi: 10.1016/j.transproceed.2007.03.003.
10
Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors.活体肝移植供者评估结果:单中心 132 例供者分析。
Hepatobiliary Pancreat Dis Int. 2011 Oct;10(5):480-8. doi: 10.1016/s1499-3872(11)60082-9.

引用本文的文献

1
The Impact of Donor Body Mass Index on Safety and Outcomes in Living Donor Liver Transplantation: An Analysis of the National United States Database.供体体重指数对活体肝移植安全性和预后的影响:基于美国国家数据库的分析
Transplant Direct. 2024 Jun 20;10(7):e1673. doi: 10.1097/TXD.0000000000001673. eCollection 2024 Jul.
2
Prognostic Factors of Liver Transplantation for HCC: Comparative Literature Review.肝癌肝移植的预后因素:文献比较综述。
J Gastrointest Cancer. 2021 Dec;52(4):1223-1231. doi: 10.1007/s12029-021-00730-x. Epub 2021 Dec 9.
3
Liver Living Donation for Cancer Patients: Benefits, Risks, Justification.
肝癌患者的活体肝移植:获益、风险与适应证。
Recent Results Cancer Res. 2021;218:135-148. doi: 10.1007/978-3-030-63749-1_10.
4
Should living donor liver transplantation be an option when deceased donation is not?当无法进行尸体捐献时,活体供肝移植是否应该成为一种选择?
J Hepatol. 2018 May;68(5):1076-1082. doi: 10.1016/j.jhep.2017.10.024. Epub 2017 Nov 1.
5
Analysis of risk factors affecting coagulopathy after donor hepatectomy in a newly established liver transplant center.新成立的肝移植中心供体肝切除术后凝血病影响因素分析
Turk J Surg. 2017 Jun 1;33(2):69-75. doi: 10.5152/turkjsurg.2017.3352. eCollection 2017.
6
The donor advocacy team: a risk management program for living organ, tissue, and cell transplant donors.供体宣传团队:一项针对活体器官、组织和细胞移植供体的风险管理计划。
Surg Today. 2017 Aug;47(8):980-985. doi: 10.1007/s00595-017-1468-z. Epub 2017 Feb 15.
7
Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients.多中心回顾性队列研究肝移植受者血流感染的流行病学
Transplant Direct. 2016 Feb 22;2(3):e67. doi: 10.1097/TXD.0000000000000573. eCollection 2016 Mar.
8
Donor Safety in Adult-Adult Living Donor Liver Transplantation: A Single-Center Experience of 356 Cases.成人-成人活体肝移植中供体的安全性:356例单中心经验
Med Sci Monit. 2016 May 14;22:1623-9. doi: 10.12659/msm.898440.
9
Challenges and Outcome of Left-lobe Liver Transplants in Adult Living Donor Liver Transplants.成人活体肝移植中左半肝移植的挑战与结果
J Clin Exp Hepatol. 2012 Jun;2(2):181-7. doi: 10.1016/S0973-6883(12)60106-6. Epub 2012 Jul 21.
10
Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study.活体供肝移植后的肝脏再生:成人对成人活体供肝移植队列研究。
Liver Transpl. 2015 Jan;21(1):79-88. doi: 10.1002/lt.23966. Epub 2014 Oct 6.